Allergy Therapeutics PLC has received a notification of major holdings from ZQ Capital Management Limited, Sky Gem Acquisition Limited, ZQ Capital Limited, and SHEN Zheqing. The notification states that the total positions of these entities in Allergy Therapeutics PLC amount to 65.453% of voting rights, with 65.103% being held directly and 0.350% being held through financial instruments. The total number of voting rights held in the company is 3,114,898,199. This represents an increase from the previous notification, where the total positions amounted to 60.310% of voting rights.
The notification also provides details of the voting rights attached to shares. The ISIN code of the shares is GB00B02LCQ05, and the number of voting rights is 3,098,231,533, representing 65.103% of voting rights. In addition, there are financial instruments in the form of warrants that may be exercised, which would result in the acquisition of 16,666,666 voting rights, representing 0.350% of voting rights.
The person subject to the notification obligation, SHEN Zheqing, is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in Allergy Therapeutics PLC. The notification also provides information on the chain of controlled undertakings through which the voting rights and financial instruments are effectively held.
The notification was completed in Hong Kong on the date specified. No additional information was provided.